Midwest Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.9K Sell
373
-188
-34% -$22K 0.02% 97
2026
Q1
$67.5K Buy
561
+300
+115% +$34.6K 0.03% 86
2025
Q4
$27.5K Hold
261
0.01% 109
2025
Q3
$21.9K Hold
261
0.01% 117
2025
Q2
$20.7K Hold
261
0.01% 118
2025
Q1
$23.4K Hold
261
0.01% 106
2024
Q4
$26K Buy
+261
New +$26.9K 0.02% 113

Other funds holding MRK

Midwest Capital Advisors's MRK Position: Q2 2026 in Review

Midwest Capital Advisors reduced its Merck (MRK) stake by 34% in Q2 2026, selling an estimated $22K and leaving 373 shares worth $47.9K. The position accounts for 0.02% of the portfolio, ranked #97.

Midwest Capital Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $67.5K in Q1 2026. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Midwest Capital Advisors held 373 shares of Merck worth $47.9K as of Q2 2026.
  • Midwest Capital Advisors sold 188 Merck shares in Q2 2026, an estimated $22K.
  • Merck made up 0.02% of Midwest Capital Advisors's portfolio in Q2 2026, its #97 holding.
  • Midwest Capital Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Midwest Capital Advisors's Merck position peaked at $67.5K in Q1 2026.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Midwest Capital Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.